
|Videos|September 7, 2021
Dr. Sarah Faris assesses tramadol and alternatives to opioid prescriptions
Author(s)Urology Times staff
“We have to be really careful prescribing tramadol and be aware that [it] can have really variable effects for patients,” says Sarah F. Faris, MD.
Advertisement
In this video, Sarah F. Faris, MD, discusses the risk of prescribing tramadol to patients and how her institution is currently developing ERAS pathways to minimize those prescriptions. Faris is an associate professor of surgery at the University of Chicago, Illinois.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Testosterone deficiency: FAQs from the AUA guideline
3
Joshua Lang, MD, MS, on integrating molecular biomarkers into clinical practice
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5












